Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C25H24N4O2 |
| Molecular Weight | 412.4837 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCCN1C=C(C2=C1C=CC=C2)C3=C(C(=O)NC3=O)C4=CNC5=C4C=CC=C5
InChI
InChIKey=QMGUOJYZJKLOLH-UHFFFAOYSA-N
InChI=1S/C25H24N4O2/c1-28(2)12-7-13-29-15-19(17-9-4-6-11-21(17)29)23-22(24(30)27-25(23)31)18-14-26-20-10-5-3-8-16(18)20/h3-6,8-11,14-15,26H,7,12-13H2,1-2H3,(H,27,30,31)
| Molecular Formula | C25H24N4O2 |
| Molecular Weight | 412.4837 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1874734
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1874734
GF109203X (GO-6850) displayed high selectivity for protein kinase C (PKC) isoenzymes. GF109203X (GO-6850) is a competitive PKC inhibitor with respect to ATP. As PKC is a central enzyme that modulates numerous biological functions GF109203X is extensively used as a tool for studying the involvement of PKC in signal transduction pathways.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26670183 | https://www.ncbi.nlm.nih.gov/pubmed/11786500
Curator's Comment: GF109203X (GO-6850) is CNS active in animals. No human data available.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1874734
Curator's Comment: Toullec et al., 1991. Laboratoires Glano, Centre de Recherches, 91951 Les Ulis, France
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL299 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1874734 |
20.0 nM [IC50] | ||
Target ID: CHEMBL3045 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1874734 |
17.0 nM [IC50] | ||
Target ID: CHEMBL2938 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1874734 |
20.0 nM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms. | 2001-08-03 |
|
| The effect of aliphatic, naphthenic, and aromatic hydrocarbons on production of reactive oxygen species and reactive nitrogen species in rat brain synaptosome fraction: the involvement of calcium, nitric oxide synthase, mitochondria, and phospholipase A. | 2001-07-01 |
|
| Role of zinc in pulmonary endothelial cell response to oxidative stress. | 2001-07 |
|
| Post-ischemic PKC inhibition impairs myocardial calcium handling and increases contractile protein calcium sensitivity. | 2001-07 |
|
| Calyculin-A induces focal adhesion assembly and tyrosine phosphorylation of p125(Fak), p130(Cas), and paxillin in Swiss 3T3 cells. | 2001-07 |
|
| DNA binding of TEA/ATTS domain factors is regulated by protein kinase C phosphorylation in human choriocarcinoma cells. | 2001-06-29 |
|
| Phosphorylation of RGS9-1 by an endogenous protein kinase in rod outer segments. | 2001-06-22 |
|
| Protein kinase C-mediated down-regulation of MDR3 mRNA expression in Chang liver cells. | 2001-06-01 |
|
| TSH-induced differentiated functions correlate with enhancement of phosphotyrosine phosphatase activity in thyroid cells. Effect of phorbol 12-myristate 13-acetate. | 2001-06 |
|
| Possible involvement of Rho kinase in Ca2+ sensitization and mobilization by MCh in tracheal smooth muscle. | 2001-06 |
|
| Calcium-sensing receptor activation induces intracellular calcium oscillations. | 2001-06 |
|
| Hypoxia alters the sensitivity of the L-type Ca(2+) channel to alpha-adrenergic receptor stimulation in the presence of beta-adrenergic receptor stimulation. | 2001-05-25 |
|
| Receptor-mediated inhibition of G protein-coupled inwardly rectifying potassium channels involves G(alpha)q family subunits, phospholipase C, and a readily diffusible messenger. | 2001-05-18 |
|
| Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. | 2001-05-11 |
|
| Phosphorylation of murine homeodomain protein Dlx3 by protein kinase C. | 2001-05-04 |
|
| Saturated non-esterified fatty acids stimulate de novo diacylglycerol synthesis and protein kinase c activity in cultured aortic smooth muscle cells. | 2001-05 |
|
| Analysis of the signal pathways involved in the regulation of fatty acid synthase gene expression by insulin and somatotropin. | 2001-05 |
|
| Effects of insulin-like growth factor-1 on retinal endothelial cell glucose transport and proliferation. | 2001-05 |
|
| Extracellular ATP stimulates an inhibitory pathway towards growth factor-induced cRaf-1 and MEKK activation in astrocyte cultures. | 2001-05 |
|
| Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. | 2001-05 |
|
| Protein kinase C regulation of dopamine transporter initiated by nicotinic receptor activation in slices of rat prefrontal cortex. | 2001-05 |
|
| Leukotriene D(4) affects localisation of vinculin in intestinal epithelial cells via distinct tyrosine kinase and protein kinase C controlled events. | 2001-05 |
|
| Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity. | 2001-05 |
|
| Importance of PKC and PI3Ks in ethanol-induced contraction of cerebral arterial smooth muscle. | 2001-05 |
|
| Key role of PKC and Ca2+ in EGF protection of microtubules and intestinal barrier against oxidants. | 2001-05 |
|
| Differential effects of growth hormone and insulin-like growth factor I on human endothelial cell migration. | 2001-05 |
|
| Pertussis toxin directly activates endothelial cell p42/p44 MAP kinases via a novel signaling pathway. | 2001-05 |
|
| Protein kinase C-mediated desensitization of the neurokinin 1 receptor. | 2001-05 |
|
| Hypoxic enhancement of evoked noradrenaline release from the human neuroblastoma SH-SY5Y. | 2001-04-18 |
|
| Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirus. | 2001-04-15 |
|
| Altered expression of glutamate transporters under hypoxic conditions in vitro. | 2001-04-15 |
|
| Use of A-192621 to provide evidence for involvement of endothelin ET(B)-receptors in endothelin-1-mediated cardiomyocyte hypertrophy. | 2001-04-13 |
|
| Ischemic preconditioning upregulates vascular endothelial growth factor mRNA expression and neovascularization via nuclear translocation of protein kinase C epsilon in the rat ischemic myocardium. | 2001-04-13 |
|
| Modulation of rat erg1, erg2, erg3 and HERG K+ currents by thyrotropin-releasing hormone in anterior pituitary cells via the native signal cascade. | 2001-04-01 |
|
| Chemorepellent signaling through the PACAP/lysozyme receptor is mediated through cAMP and PKC in Tetrahymena thermophila. | 2001-04 |
|
| Protein kinase C alpha modulates the Ca2+ influx phase of the Ca2+ response to 1alpha,25-dihydroxy-vitamin-D3 in skeletal muscle cells. | 2001-04 |
|
| Phorbol ester differentially regulates oxytocin receptor binding activity in hypothalamic cultured neurons and astrocytes. | 2001-04 |
|
| Signal transduction pathways for activation of extracellular signal-regulated kinase by arachidonic acid in rat neutrophils. | 2001-04 |
|
| Mechanisms of thrombin-induced MAPK activation associated with cell proliferation in human cultured tracheal smooth muscle cells. | 2001-04 |
|
| Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels. | 2001-04 |
|
| The role of protein kinase C in the regulation of serotonin-2A receptor expression. | 2001-04 |
|
| Interaction of CD163 with the regulatory subunit of casein kinase II (CKII) and dependence of CD163 signaling on CKII and protein kinase C. | 2001-04 |
|
| Cyclization strategies for the synthesis of macrocyclic bisindolylmaleimides. | 2001-03-23 |
|
| Thrombin activates p38 mitogen-activated protein kinase in vascular smooth muscle cells. | 2001-03-16 |
|
| Upregulation of p21(WAF1/CIP1) leads to morphologic changes and esterase activity in TPA-mediated differentiation of human prostate cancer cell line TSU-Pr1. | 2001-03-08 |
|
| Progesterone effect mediated by the voltage-dependent calcium channel and protein kinase C on noncapacitated cryopreserved bovine spermatozoa. | 2001-03 |
|
| ATP stimulated cyclic AMP formation in bovine chromaffin cells is enhanced by neuropeptide Y. | 2001-03 |
|
| Protein kinase C-dependent and -independent inhibition of Ca(2+) influx by phorbol ester in rat pancreatic beta-cells. | 2001-03 |
|
| Potent direct inhibition of mammalian phospholipase D isoenzymes by calphostin-c. | 2001-02-27 |
|
| Protein tyrosine kinase-dependent regulation of adenylate cyclase and phosphatidylinositol 3-kinase activates the expression of glial fibrillary acidic protein upon induction of differentiation in rat c6 glioma. | 2001 |
Patents
Sample Use Guides
In a murine model of delayed type hypersensitivity, GF109203X (GO-6850) inhibited dinitrofluorobenzene-induced contact dermatitis with and ID50 value of 150 micrograms/ear.
Intrahippocampal GF109203X (GO-6850) 0.3-30 pg/site modulates memory reconsolidation in rats. Rats that were pretreated with GF109203X (GO-6850) 0.12 mg/kg by intramuscular injection had less pulmonary edema induced by the high tidal volume ventilation.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8904648
After pretreatment of cells with GF109203X (GO-6850) (5 microM, 45 min), the histamine (100 microM)-induced initial rise in [Ca2+]i, representing Ca2+ mobilization from internal stores, was inhibited in in DDT1 MF-2 smooth muscle cells.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:03:36 GMT 2025
by
admin
on
Mon Mar 31 22:03:36 GMT 2025
|
| Record UNII |
L79H6N0V6C
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2396
Created by
admin on Mon Mar 31 22:03:36 GMT 2025 , Edited by admin on Mon Mar 31 22:03:36 GMT 2025
|
PRIMARY | |||
|
DTXSID50157932
Created by
admin on Mon Mar 31 22:03:36 GMT 2025 , Edited by admin on Mon Mar 31 22:03:36 GMT 2025
|
PRIMARY | |||
|
DB03777
Created by
admin on Mon Mar 31 22:03:36 GMT 2025 , Edited by admin on Mon Mar 31 22:03:36 GMT 2025
|
PRIMARY | |||
|
L79H6N0V6C
Created by
admin on Mon Mar 31 22:03:36 GMT 2025 , Edited by admin on Mon Mar 31 22:03:36 GMT 2025
|
PRIMARY | |||
|
133052-90-1
Created by
admin on Mon Mar 31 22:03:36 GMT 2025 , Edited by admin on Mon Mar 31 22:03:36 GMT 2025
|
PRIMARY | |||
|
Bisindolylmaleimide I
Created by
admin on Mon Mar 31 22:03:36 GMT 2025 , Edited by admin on Mon Mar 31 22:03:36 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |